Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholders notes

I have been told that PR will finally pick up, considerably.. that is one thing that Turley/BOD can actually do to try to support share price..

Share price IMO will still mostly reflect litigation, uncertainty, and the results that come.. It doesn't matter, certainly in the near term, what M&A activity PTSC engages in.. a loss in Tex and people will bail big time and pps will reflect this.. eventually the share price may recover depending on the M&A road PTSC chooses.. but, right now, it is all about Tex and that's about it...

jmo

 

Share
New Message
Please login to post a reply